BIOLIFE SOLUTIONS INC — Form 8-K
Filed October 6, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
BioLife Solutions adopted an Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, both effective October 6, 2026. The Certificate authorizes 1,000 shares of common stock at $0.001 par value. The Bylaws establish standard governance structure (board discretion on size, plurality voting for directors, majority vote for other matters), director/officer indemnification provisions, remote meeting capabilities, and written consent rights requiring 60-day delivery window. No specific material transactions, counterparties, or financial impacts are disclosed.
Why this rating
Routine governance amendment. No strategic business change, no material financial impact, no counterparty dealings. Procedural document modernizing bylaws for remote participation and clarifying indemnification—standard for public companies but immaterial to $845M market cap company operations.
See more from October 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.